rs112549942
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_003036.4(SKI):c.1474+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000031 in 1,612,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003036.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Shprintzen-Goldberg syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, PanelApp Australia, G2P, Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SKI | ENST00000378536.5 | c.1474+1G>A | splice_donor_variant, intron_variant | Intron 4 of 6 | 1 | NM_003036.4 | ENSP00000367797.4 | |||
| SKI | ENST00000507179.1 | n.458G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
| SKI | ENST00000704337.1 | n.*195G>A | downstream_gene_variant | 
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152194Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome  AF:  0.00000274  AC: 4AN: 1460062Hom.:  0  Cov.: 32 AF XY:  0.00000275  AC XY: 2AN XY: 726320 show subpopulations 
Age Distribution
GnomAD4 genome  0.00000657  AC: 1AN: 152194Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74340 show subpopulations 
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection    Uncertain:1 
The c.1474+1G>A intronic variant results from a G to A substitution one nucleotide after coding exon 4 of the SKI gene. This nucleotide position is highly conserved in available vertebrate species. Using the ESEfinder and Human Splicing Finder (HSF) splice site prediction tools, this alteration is predicted to abolish and weaken, respectively, the native splice donor site; however, direct evidence is unavailable (Desmet FO et al. Nucleic Acids Res. 2009 May;37(9):e67). The BDGP splice prediction software does not produce a reliable prediction for the nearby native splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. However, loss of function of SKI has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at